The purpose of this limited competition notice of funding opportunity (NOFO) is to continue the support of the Clinical Sites of the NASH Clinical Research Network (NASH CRN) as they complete active clinical treatment trials and continue to longitudinally gather biospecimens and data of children and adults with nonalcoholic fatty liver disease (NAFLD), including steatosis, steatohepatitis, and cirrhosis (NAFLD database study). The NASH CRN has been sponsored by the NIDDK since 2002, and renewed in 2009 and 2014. Research in the NASH CRN has been focused on the etiology, contributing factors, natural history, complications, and therapy of nonalcoholic steatohepatitis.
Deadlines:
-
Letter of Intent Due Date(s): October 8, 2023
-
Renewal / Resubmission / Revision Due Date: November 08, 2023
RFA-DK-23-515 Expiration Date November 09, 2023
Only the currently participating NASH CRN Program Director(s)/Principal Investigator(s) are eligible to apply to this NOFO. At Duke, this is Anna Mae Diehl.
Initial awards will be up to $250,000 direct costs per year. Based on project data provided in the annual RPPR, some awards may be adjusted (e.g., reduced or increased above the initial budget threshold) to accommodate recruitment and other scientific and patient care needs associated with the networks operations and approved aims.
The maximum project period is 3 years.